Summary
Updated Aug 31, 2026
Katherine Goodrich is Director of Tarsus Pharmaceuticals, Inc. (TARS). 5 SEC Form 4 filings on record going back to 2024, most recently on 29 June 2026. Most recent open-market trade: sold $183K of TARS on 17 June 2026. Lifetime open-market sales: $183K.
Recent Transactions
3Every recent SEC Form 4 transaction Katherine Goodrich has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Katherine Goodrich go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. 1 recorded transaction carries a Rule 10b5-1 flag, meaning it was pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Katherine Goodrich files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bobak R. Azamian - $3.31M of TARS open-market activity in the last 12 months
- William J. Phd Link - $3.18M of TARS open-market activity in the last 12 months
- Seshadri Neervannan - $1.61M of TARS open-market activity in the last 12 months
- Jeffrey S. Farrow - $1.32M of TARS open-market activity in the last 12 months
- Aziz Mottiwala - $893K of TARS open-market activity in the last 12 months
- Bryan Wahl - $850K of TARS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Katherine Goodrich?
Katherine Goodrich is a corporate insider, tracked as Director of Tarsus Pharmaceuticals, Inc. (TARS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Katherine Goodrich submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Katherine Goodrich been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($183K) across all tracked filings.
Where can I see all of Katherine Goodrich's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Katherine Goodrich and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial